Dr. Edmund Pribitkin
Dr. Pribitkin is a professor at Thomas Jefferson University where he serves as the Academic Vice-Chairman of the Department of Otolaryngology-Head & Neck Surgery and directs the Otolaryngology Residency Training Program. He has been certified by two specialty boards and is a fellow of the American Academy of Facial Plastic and Reconstructive Surgery, the American Academy of Otolaryngology-Head & Neck Surgery, the American Rhinologic Society, the Triological Society and the American College of Surgeons.
Dr. Pribitkin serves as the associate editor of facial plastic surgery for the Laryngoscope, his specialty’s highest impact journal. He received his undergraduate degree from Johns Hopkins University, his medical degree from the University of Pennsylvania School of Medicine and, most recently, an MBA from The Wharton School of Business in May, 2016.
A recipient of the Dean’s Outstanding Clinician Award, Dr. Pribitkin is regularly listed as one of Philadelphia’s Top Docs by Philadelphia magazine and one of America’s Top Docs by Castle Connolly. His career has been characterized by continuing innovations in patient care. Dr. Pribitkin co-authored the first dose-response paper on Botox for facial wrinkles. He introduced laser surgery for sleep apnea and for facial wrinkles to Philadelphia. He has devised new techniques for the repair of parotid defects and for the closure of nasal septal perforations. He also pioneered the use of ultrasonic technology in rhinoplasty, orbital and sinus surgery, and co-founded the Jefferson Thyroid and Parathyroid Center, the first multi-disciplinary center of its kind in the region. As an affiliated scientist of the Monell Chemosensory Center, he also directed the Jefferson-Monell Clinical Smell and Taste Center and been a key co-investigator on several NIH programmatic grants.
Dr. Pribitkin has authored over 100 peer-reviewed papers and has lectured throughout the world. His current research initiatives involve determining how exercise can reverse the effects of aging on flap viability and how it can counteract the harmful effects of radiation. He is also exploring new ways of culturing stem cells to grow olfactory neurons with the hope of restoring the sense of smell to the millions of American’s suffering with anosmia. He continues to work with his collaborators in endocrinology and pathology to develop new genetic tests that personalize the treatment of thyroid cancer.
Jefferson has been Dr. Pribitkin’s professional home for a quarter century. As Dr. Pribitkin says, “At Jefferson, we are blessed with a premier medical facility dedicated to personalized care. We value each patient's individual healing experience. Accordingly, everyone in our office and in our hospital is dedicated to making that experience a positive and enduring one. Like the famous surgeon, William Osler, we realize that 'patients don't care how much you know until they know how much you care.' At Jefferson, listening and understanding catalyze innovations in healing."